• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

MASUPIRDINE Drug Record

  • Summary
  • Interactions
  • Claims
  • MASUPIRDINE chembl:CHEMBL4117187

    Alternate Names:

    SUVN-502
    MASUPIRDINE

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications for treatment of Alzheimer's disease
    (0 More Sources)

    Publications:

    Nirogi RV et al., 2010, Novel and Potent 5-Piperazinyl Methyl-N 1-aryl Sulfonyl Indole Derivatives as 5-HT6 Receptor Ligands., ACS Med Chem Lett
  • MASUPIRDINE   HTR6

    Interaction Score: 16.86

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name SUVN-502
    Novel drug target Established target

    PMIDs:
    24900216


    Sources:
    TdgClinicalTrial TTD

  • TdgClinicalTrial: SUVN-502

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications for treatment of Alzheimer's disease
    Drug Class small molecule
    FDA Approval not approved

    Publications:

  • TTD: SUVN-502

    • Version: 2020.06.01

    Alternate Names:
    D0Z0GX TTD Drug ID

    Drug Info:

    Publications:
    Nirogi RV et al., 2010, Novel and Potent 5-Piperazinyl Methyl-N 1-aryl Sulfonyl Indole Derivatives as 5-HT6 Receptor Ligands., ACS Med Chem Lett

  • ChemblDrugs: chembl:CHEMBL4117187

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21